Apixaban Cuts Stroke But Ups Bleeding in Subclinical AF
Further analyses from the ARTESIA study and the previous NOAH-AFNET 6 trial are needed to try to identify groups where the benefit may outweigh the risk, researchers say.
Source: medscape.com
Stay updated with breaking news from Prevention Intervention Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Further analyses from the ARTESIA study and the previous NOAH-AFNET 6 trial are needed to try to identify groups where the benefit may outweigh the risk, researchers say.